BGSF, Inc.: Form 10-Q for the period ended Jul 2, 2023
Filed with the SEC on Aug 9, 2023 and accepted by EDGAR at Aug 9, 2023, 17:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-03 to 2023-07-02 | $80.8k | us-gaap:Revenues |
| Revenue | 6 months2023-01-02 to 2023-07-02 | $156.1k | us-gaap:Revenues |
| Cost of revenue | 3 months2023-04-03 to 2023-07-02 | $51.2k | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-01-02 to 2023-07-02 | $99.8k | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-04-03 to 2023-07-02 | $29.6k | us-gaap:GrossProfit |
| Gross profit | 6 months2023-01-02 to 2023-07-02 | $56.4k | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-04-03 to 2023-07-02 | $22.6k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-01-02 to 2023-07-02 | $45.8k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-04-03 to 2023-07-02 | $5.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-02 to 2023-07-02 | −$15.7k | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2023-04-03 to 2023-07-02 | $2.6k | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-02 to 2023-07-02 | −$13.9k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-03 to 2023-07-02 | $0.24 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-02 to 2023-07-02 | −$1.29 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-03 to 2023-07-02 | $0.24 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-02 to 2023-07-02 | −$1.29 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-03 to 2023-07-02 | 10,770 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-02 to 2023-07-02 | 10,731 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-02 to 2023-07-02 | $12.5k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-04-03 to 2023-07-02 | $745 | us-gaap:PaymentsToAcquireProductiveAssets |
| Capital expenditure | 6 months2023-01-02 to 2023-07-02 | $1.5k | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2023-01-02 to 2023-07-02 | $3.2k | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2023-07-02 | $660 | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-02 | $69.4k | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-02 | $182.4k | us-gaap:Assets |
| Current liabilities | At period end2023-07-02 | $28.7k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-02 | $98.0k | us-gaap:Liabilities |
| Current portion of debt | At period end2023-07-02 | $4.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-07-02 | $84.4k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001474903-23-000086. Last ingested by Listed: Nov 11, 2026, 02:17 ET. Listed shows no prices and gives no investment advice.